Helixgate

Helixgate

Uncategorized

Biogen makes up to $1B immuno play with RayThera takeover

Published

on

RayThera will bring three preclinical assets into the Biogen fold, all with anti-inflammatory activity. The most mature of these assets is expected to enter Phase 1 development in Q3.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

cAMPfield lands $180M to build gut disease drug

The biotech is advancing an anti-inflammatory drug that originated with vTv for inflammatory bowel diseases, leaning on a better side effect profile.

Read More

Published

on

The biotech is advancing an anti-inflammatory drug that originated with vTv for inflammatory bowel diseases, leaning on a better side effect profile.

Read More

Continue Reading

Uncategorized

New biotech cAMPfield emerges with $180M to reshape IBD treatment

Published

on

Backed by institutional investors and seasoned industry leaders, cAMPfield Therapeutics is advancing a clinical program aimed at reshaping the landscape for inflammatory bowel disease.

Continue Reading

Uncategorized

STAT+: Shingles vaccine may lower dementia risk, new study finds

If you’re an older adult, getting vaccinated against shingles could lower your risk of developing dementia.

A new study found that elderly nursing home residents who received at least one dose of the shingles vaccine known as Shingrix, the only shot of its kind available in the United States, were 24 percent less likely to develop dementia over a four-year period compared to those who were not vaccinated, according to results published this week in the peer-reviewed journal Annals of Internal Medicine.

The research adds to the growing body of evidence showing a connection between the viral infection and cognitive decline.

Continue to STAT+ to read the full story…

Read More

Published

on

If you’re an older adult, getting vaccinated against shingles could lower your risk of developing dementia.

A new study found that elderly nursing home residents who received at least one dose of the shingles vaccine known as Shingrix, the only shot of its kind available in the United States, were 24 percent less likely to develop dementia over a four-year period compared to those who were not vaccinated, according to results published this week in the peer-reviewed journal Annals of Internal Medicine.

The research adds to the growing body of evidence showing a connection between the viral infection and cognitive decline.

Continue to STAT+ to read the full story…

Read More

Continue Reading
Advertisement

Trending